Mitsubishi Chemical Holdings earnings date
Mitsubishi Chemical Holdings (M3C) Q3 2024 Earnings Report
DE:M3C Q3 2024 EPS Results
- Actual EPS
- EUR 0.07
- Consensus EPS
- EUR 0.13
- Beat/Miss
- Missed by -EUR 0.05
- One Year Ago EPS
- EUR 0.15
DE:M3C Q3 2024 Revenue Results
- Actual Revenue
- EUR 6.16B
- Expected Revenue
- EUR 6.25B
- Beat/Miss
- Missed by -EUR 90.87M
- YoY Revenue Growth
- -0.53%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 02/06/2025
- Time
- Before Open
- Conference Call
- Thursday, February 6, 2025
Mitsubishi Chemical Holdings's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
The earnings call presented a mixed performance. Highlights included strong cost management and performance in industrial gases and healthcare. However, significant challenges were noted in specialty and basic materials, as well as ongoing struggles in the MMA and carbon businesses.
During the third quarter earnings call for Mitsubishi Chemical Group, several financial metrics were highlighted by the executives. The company's core operating income for the year-to-date reached JPY 183.9 billion, surpassing forecasts despite the challenging economic conditions in the chemical industry. Strong positive cash flow was reported at JPY 165.7 million, with cost reductions amounting to JPY 82 billion, exceeding the annual target of JPY 80 billion. The balance sheet showed continued improvement with a net debt-to-equity ratio of 1.2. Revenue declined by 5% year-on-year to JPY 3,245.1 billion, while core operating income saw a 3% year-on-year increase. Specialty Materials experienced a significant 69% drop in profit, while Industrial Gases and the Healthcare sector reported profit increases of 45% and 177%, respectively. The average exchange rate was JPY 143.8 to the dollar, and naphtha prices fell 15% year-on-year to JPY 67,900. The company maintained its full-year earnings forecast, emphasizing ongoing cost management and restructuring efforts.
- Strong Financial Performance Amid Industry DownturnMCG delivered a better-than-forecast core operating income of JPY 183.9 billion, and a positive cash flow of JPY 165.7 million, despite the prolonged chemical industry downturn.
- Cost Reductions Surpassed Annual TargetsAchieved JPY 82 billion in cost reductions, exceeding the full-year target of JPY 80 billion, contributing to securing profits.
- Industrial Gases and Healthcare PerformanceIndustrial gases saw a sales increase of 6% and profits up by 45%. Healthcare sales rose 6% with a 177% profit increase due to RADICAVA sales in the U.S.
DE:M3C Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q3) | 0.13- | -0.02 | ― | ― |
| Nov 05, 2026 | 2026 (Q2) | 0.100.14 | 0.37 | -63.62% (-0.24) | |
| Jul 31, 2026 | 2026 (Q1) | 0.100.24 | 0.08 | 204.23% (+0.16) | |
| May 13, 2026 | 2025 (Q4) | -0.22-0.38 | -0.06 | -575.30% (-0.33) | |
| Feb 05, 2026 | 2025 (Q3) | 0.06-0.02 | 0.07 | -122.84% (-0.09) | |
| Oct 31, 2025 | 2025 (Q2) | 0.410.37 | 0.01 | 7282.02% (+0.37) | |
| Aug 01, 2025 | 2025 (Q1) | 0.140.08 | 0.16 | -49.91% (-0.08) | |
| May 13, 2025 | 2024 (Q4) | 0.01-0.06 | 0.04 | -261.69% (-0.09) | |
| Feb 06, 2025 | 2024 (Q3) | 0.130.07 | 0.15 | -49.71% (-0.07) | |
| Nov 01, 2024 | 2024 (Q2) | 0.030.01 | 0.1 | -94.87% (-0.09) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


